pemetrexed and cisplatin

DRUG3 trials

Sponsors

CanBas Co. Ltd., GlaxoSmithKline, Memorial Sloan Kettering Cancer Center

Conditions

Lung Cancer, Non-Small CellMalignant Pleural MesotheliomaMesotheliomaSolid Tumors

Phase 1

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)

CompletedNCT00700336

CanBas Co. Ltd.Malignant Pleural Mesothelioma, Solid Tumors

Start: 2008-05-31End: 2012-11-30Updated: 2021-07-20

Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma

TerminatedNCT03319537

Memorial Sloan Kettering Cancer CenterMesothelioma

Start: 2017-10-05End: 2023-06-05Updated: 2024-05-23

Phase 2

Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer

CompletedNCT00871403

GlaxoSmithKlineLung Cancer, Non-Small Cell

Start: 2009-07-31End: 2011-03-31Updated: 2013-06-20